These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32221533)
1. Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens. Böttinger P; Schreiber K; Hyjek E; Krausz T; Spiotto MT; Steiner M; Idel C; Booras H; Beck-Engeser G; Riederer J; Willimsky G; Wolf SP; Karrison T; Jensen E; Weichselbaum RR; Nakamura Y; Yew PY; Lambert PF; Kurita T; Kiyotani K; Leisegang M; Schreiber H Carcinogenesis; 2020 Nov; 41(11):1605-1615. PubMed ID: 32221533 [TBL] [Abstract][Full Text] [Related]
2. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
3. Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells. Smith SP; Scarpini CG; Groves IJ; Odle RI; Coleman N Sci Rep; 2016 Jul; 6():29832. PubMed ID: 27457222 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population. Zhou Z; Yang H; Yang L; Yao Y; Dai S; Shi L; Li C; Yang L; Yan Z; Yao Y Infect Genet Evol; 2019 Sep; 73():13-20. PubMed ID: 30981880 [TBL] [Abstract][Full Text] [Related]
5. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058 [TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Shai A; Brake T; Somoza C; Lambert PF Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103 [TBL] [Abstract][Full Text] [Related]
7. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice. Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696 [TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257 [TBL] [Abstract][Full Text] [Related]
9. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women. Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809 [TBL] [Abstract][Full Text] [Related]
10. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer. Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis. Shin MK; Balsitis S; Brake T; Lambert PF Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294 [TBL] [Abstract][Full Text] [Related]
12. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
13. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells. Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma. Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells. Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048 [TBL] [Abstract][Full Text] [Related]
16. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer. Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK Virol J; 2016 Apr; 13():60. PubMed ID: 27044426 [TBL] [Abstract][Full Text] [Related]
17. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo. Hu D; Zhou J; Wang F; Shi H; Li Y; Li B Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522 [TBL] [Abstract][Full Text] [Related]
18. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis. Balsitis S; Dick F; Dyson N; Lambert PF Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593 [TBL] [Abstract][Full Text] [Related]
19. HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model for HPV-related penile cancer. Medeiros-Fonseca B; Mestre VF; Estêvão D; Sánchez DF; Cañete-Portillo S; Fernández-Nestosa MJ; Casaca F; Silva S; Brito H; Félix A; Medeiros R; Colaço B; Oliveira PA; Bastos MM; Nelson PS; Vakar-Lopez F; Gaivão I; Brito L; Lopes C; Cubilla AL; Gil da Costa RM J Pathol; 2020 Aug; 251(4):411-419. PubMed ID: 32488868 [TBL] [Abstract][Full Text] [Related]
20. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]